550997-55-2

550997-55-2 structure
550997-55-2 structure
  • Name: ERB-196
  • Chemical Name: 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthalene-1-carbonitrile
  • CAS Number: 550997-55-2
  • Molecular Formula: C17H10FNO2
  • Molecular Weight: 279.26500
  • Catalog: Research Areas Inflammation/Immunology
  • Create Date: 2016-02-06 22:49:06
  • Modify Date: 2024-01-11 18:14:45
  • ERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist.

Name 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthalene-1-carbonitrile
Synonyms 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
1yye
3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile
1-Naphthalenecarbonitrile,3-(3-fluoro-4-hydroxyphenyl)-7-hydroxy
ERB-196
Description ERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist.
Related Catalog
Target

ERβ[1]

In Vivo ERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist. ERB-196 significantly reduces histopathologic evidence of injury to the gastrointestinal mucosal surface (0.7±0.1 vs. 2.3±0.2 for control; p<0.05). The mucosal mass of 10-cm segments of small bowel mucosa shows better preservation of mucosal mass than control treatment (63±20 [ERB-196] vs. 31±24 [control]), but this difference fails to reach statistical significance (p<0.06). The administration of ERB-196 is highly effective in the prevention of lethality. Consistent with the neutropenic rat model, ERB-196 significantly increases survival when compare with vehicle control[1].
Animal Admin The neutropenic rat model of pseudomonas sepsis are used in this study. For the survival study, ERB-196 (50 mg/kg; n=12) or vehicle control (n=8) is administered daily by orogastric feeding beginning on day 4 after the first dose of cyclophosphamide and continuing for 8 days. Animals are assessed clinically and pathologically by measuring daily body weight, body temperature, presence of bacteremia, circulating endotoxin levels, and pathologic evidence of damage to the gastrointestinal epithelium and liver by light microscopy and electron microscopy. Blood and tissue samples are serially diluted in sterile saline and incubated at 37°C on pseudomonas agar for quantitative assessment of bacterial concentrations[1].
References

[1]. Cristofaro PA, et al. WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med. 2006 Aug;34(8):2188-93.

Molecular Formula C17H10FNO2
Molecular Weight 279.26500
Exact Mass 279.07000
PSA 64.25000
LogP 3.92878
Storage condition 2-8℃

~%

550997-55-2 structure

550997-55-2

Literature: WYETH Patent: US2008/214507 A1, 2008 ; Location in patent: Page/Page column 5-6 ;

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~%

550997-55-2 structure

550997-55-2

Literature: Mewshaw, Richard E.; Edsall Jr., Richard J.; Yang, Cuijian; Manas, Eric S.; Xu, Zhang B.; Henderson, Ruth A.; Keith Jr., James C.; Harris, Heather A. Journal of Medicinal Chemistry, 2005 , vol. 48, # 12 p. 3953 - 3979

~71%

550997-55-2 structure

550997-55-2

Literature: Wyeth Patent: US2003/181519 A1, 2003 ;